Windtree Therapeutics Secures Hong Kong Patent for Istaroxime in Heart Failure Treatment
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the issuance of a new patent for istaroxime in Hong Kong, titled “Istaroxime-containing intravenous formulation for the treatment of heart …
Windtree Therapeutics Secures Hong Kong Patent for Istaroxime in Heart Failure Treatment Read More